Future leaders in research recognised with Parkinson’s UK funding award Date 11 February 2025 Nearly £600,000 has been awarded to 2 outstanding scientists to develop their Parkinson’s research careers.
Results from the phase 3 trial of exenatide published Date 4 February 2025 The full results show that exenatide had no benefits over the placebo and didn’t slow the progression of Parkinson’s.
Adaptive deep brain stimulation in the news Date 29 January 2025 Adaptive deep brain stimulation in the news
Blood pressure drug shows promise for reducing tremor in Parkinson’s Date 9 January 2025 A small study of a drug called propranolol looked effective in easing tremor both at rest and in stressful situations for people with Parkinson’s.
Our trial of ondansetron as a treatment for hallucinations in Parkinson's is restarting Date 22 November 2024 The TOP HAT trial was halted in April. We’re delighted to announce that it is restarting.
Parkinson’s UK awards £1m to new research projects Date 5 November 2024 Parkinson’s UK has granted funding to projects aiming to advance our understanding of the causes and symptoms of Parkinson’s, as well as exploring new treatments.
Results from the phase 3 trial of exenatide shared with participants Date 15 October 2024 The results indicate that people in the study who received exenatide did not benefit compared to those who received placebo - suggesting that the drug does not slow down the progression of Parkinson’s.
Pioneering Landmark project launches Date 23 September 2024 Parkinson’s UK led consortium is using big data to accelerate new treatment options, aiming to unlock a cure for Parkinson’s.
We're investing in the Beech Band, a wearable device that aims to manage Parkinson's symptoms Date 20 September 2024 The Beech Band, designed by Carl Beech, is a wearable device showing promising signs of being able to manage symptoms including speech issues, anxiety and gait.
Progress towards a form of adaptable deep brain stimulation Date 19 August 2024 A small study shows that adaptive deep brain stimulation is better than the standard version at controlling movement symptoms day and night for people with Parkinson’s.
